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Abstract Muscle regeneration is a complex phenomenon,
involving replacement of damaged fibers by new muscle
fibers. During this process, there is a tendency to form scar
tissue or fibrosis by deposition of collagen that could be
detrimental to muscle function. New therapies that could
regulate fibrosis and favor muscle regeneration would be
important for physical therapy. Low-level laser therapy
(LLLT) has been studied for clinical treatment of skeletal
muscle injuries and disorders, even though the molecular
and cellular mechanisms have not yet been clarified. The
aim of this study was to evaluate the effects of LLLT on
molecular markers involved in muscle fibrosis and regener-
ation after cryolesion of the tibialis anterior (TA) muscle in
rats. Sixty Wistar rats were randomly divided into three
groups: control, injured TA muscle without LLLT, injured
TA muscle treated with LLLT. The injured region was
irradiated daily for four consecutive days, starting immedi-
ately after the lesion using an AlGaAs laser (808 nm,
30 mW, 180 J/cm2; 3.8 W/cm2, 1.4 J). The animals were
sacrificed on the fourth day after injury. LLLT significantly
reduced the lesion percentage area in the injured muscle (p<
0.05), increased mRNA levels of the transcription factors
MyoD and myogenin (p<0.01) and the pro-angiogenic vas-
cular endothelial growth factor (p<0.01). Moreover, LLLT
decreased the expression of the profibrotic transforming
growth factor TGF-β mRNA (p<0.01) and reduced type I
collagen deposition (p<0.01). These results suggest that
LLLT could be an effective therapeutic approach for pro-
moting skeletal muscle regeneration while preventing tissue
fibrosis after muscle injury.
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Introduction
Skeletal muscle injuries are routinely found in rehabilitation
centers. They often cause a significant reduction in the
functional capacity of the patient, and are characterized by
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slow and incomplete recovery, leading to increased likeli-
hood of scar tissue formation, re-injury, atrophy, contrac-
ture, and chronic disability [1, 2].
Muscle regeneration involves several highly organized
molecular and cellular processes that ideally lead to struc-
tural and functional recovery of the injured muscle [3]. The
initial phase of this process is characterized by an inflam-
matory response and necrosis of the injured tissue leading to
activation and proliferation of adult satellite cells [1, 2, 4].
The satellite cells are myogenic precursor cells (stem cells)
that are quiescent in normal muscle fibers, located between
basal lamina and sarcolemma, and when activated, undergo
cell cycle, divide, differentiate and fuse with muscle fibers
to repair injured areas [5, 6].
Activated satellite cells increase their expression of
myoD and myf5, which are basic helix-loop-helix transcrip-
tion factors which belong to the myogenic regulatory factor
family (MRFs) [7, 8]. MyoD is rapidly expressed within
12 h post-injury [9], and the peak of expression is at day3
post-cryolesion in tibialis anterior (TA) muscle [10]. Subse-
quently, upregulation of the secondary MRFs like myogenin
and MRF4 induces terminal differentiation of myoblasts
into myocytes [4] in order to reestablish the structure and
function of muscle tissue. Therefore, myoD and myogenin
play an important role in the regeneration of skeletal muscle.
The development of new blood vessels (angiogenesis)
plays an important role in successful muscle regeneration
[11]. This process is regulated by vascular endothelial
growth factor (VEGF) that exerts multiple effects on the
vascular endothelium including stimulation of endothelial
cell proliferation, rapid induction of microvascular perme-
ability, promotion of endothelial cell survival, stimulation of
endothelial cell adhesion and migration and subsequent
connection between new vessels and the pre-existing circu-
lation [12–14]. Hence, VEGF is considered an excellent
biomarker for angiogenesis, and its expression is related to
recovery of skeletal muscle.
Skeletal muscle regeneration is regulated by growth fac-
tors, such as insulin-like growth factor-1, basic fibroblast
growth factor, hepatocyte growth factor, epidermal growth
factor, and transforming growth factor-beta (TGF-β) [4, 6].
TGF-β is a multifunctional cytokine produced by fibro-
blasts, epithelial cells, and macrophages in the lesion site.
It stimulates mesenchymal cell proliferation, collagen and
fibronectin synthesis, and is important in causing fibrosis in
several diseases [15]. Excessive production of TGF-β can
be harmful in muscle repair, as it increases formation of
fibrous non-functional scar tissue and can inhibit differenti-
ation and fusion of myoblasts, impairing the regeneration of
muscle tissue [15, 16]. Therapeutic approaches that have a
dual action by reducing fibrous scar tissue formation while
optimizing muscle repair would be helpful for rehabilitating
muscle function after injury.
Low-level laser therapy (LLLT) is considered a safe and
effective technique for the clinical treatment of a variety of
diseases and injuries [17, 18]. Positive results have been
reported with LLLT in several experimental models of skel-
etal muscle injury and repair [19–22]. This therapeutic mo-
dality was able to improve muscle repair by inducing a rapid
growth of capillary vessels in the injured area [23, 24], a
remarkable regeneration of muscle fibers [25–27] and par-
allel orientation of regenerating myofibers [28].
Although knowledge is steadily increasing concerning
the biological and molecular mechanisms of LLLT, more
studies are needed to determine which signaling path-
ways are triggered by LLLT in muscle and how the
cellular effects are translated into improved skeletal
muscle functions. This study therefore focused on ex-
ploring the effect of LLLT on skeletal muscle repair,
evaluating its effect on the molecular markers involved
in muscle regeneration and fibrosis, specifically measur-
ing MyoD, myogenin, VEGF, and TGF-β at the tran-
scriptional level as well type I collagen deposition.
Materials and methods
Experimental groups and freezing muscle injury
(cryoinjury)
Adult male Wistar rats (Rattus norvegicus) weighing 300 g
were used in this study. Good laboratory animal practice
was observed according to the international standards for
animal experimentation and following approval by our insti-
tution’s Animal Care and Ethics Committee.
The animals (n060) were randomly divided into three
groups (n020 per group): control group—animals with no
interventions (BC); injured TA muscle without treatment
(IC); injured TA muscle submitted to laser irradiation treat-
ment (IRI).
Surgical procedures (cryolesion) were performed based
on those described by Miyabara et al. [29], under anesthesia
with 1 ml/kg of 1 % ketamine HCl (Dopalen; Vetbrands;
São Paulo; Brazil) and 2 % xylazine (Anasedan; Vetbrands;
São Paulo; Brazil). After anesthesia, the skin around the
right TA muscle was shaved and cleaned. Then, a transver-
sal cut (about 1 cm) of the skin over the middle of the
muscle was carried out, exposing the muscle. A rectangular
iron bar (40×20 mm2), frozen in liquid nitrogen, was then
kept for 10 s on the center of the muscle. The procedure was
repeated twice consecutively, with a time interval of 30 s.
Finally, the skin was sutured (Fig. 1). The right TA muscle
was chosen because it is a superficial muscle, making the
surgery easy. After surgery, the animals were housed in
single plastic cages in a room with controlled environmental
conditions and fed rat chow and water ad libitum.
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LLLT protocol
LLLT was performed using a gallium-aluminum-arsenide
(GaAlAs) diode laser (PHOTON LASER II, DMC® equipa-
mentos Ltda, SP, São Carlos, Brazil), with the following
parameters: continuous radiation mode, 808 nm wavelength,
30 mW power output, 47 s irradiation time, 0.00785 cm² spot
area, dose 180 J/cm2, irradiance 3.8 W/cm2 and 1.4 J total
energy per point. A LaserCheck power meter (Coherent, Santa
Clara, CA) was used to determine the output of the equipment.
The skin having been shaved at the surgery site, the laser
was applied over one point at in the middle of right TA
muscle (lesion area). LLLT was performed daily and at the
same time for four consecutive days, with the first applica-
tion immediately after skin suturing. Laser was applied by
contact technique, with the optical fiber kept perpendicular
to the skin. The animals were handled gently, and LLLT did
not produce any painful sensation or distress to the animals.
Muscle evaluation
Animalswereweighed and euthanizedwith an anesthetic over-
dose, and the right TA muscles removed and weighed. Subse-
quently, ten animals from each group were used for
morphometric analysis and the other ten animals for real-time
polymerase chain reaction and immunoblotting analysis. For
histological evaluation, the muscle fragment was immediately
frozen in isopentane pre-cooled in liquid nitrogen, and then
stored in a freezer at −80 °C (Forma Scientific, Marietta, OH).
For further analysis, themuscle fragments from the injured site
were pulverized in liquidnitrogenwith amortar and pestle. The
proximal fragment was used for RNA extraction protocol. The
distal samples were used for the other analyses and were ho-
mogenized in RIPA buffer containing 10 mM Tris–HCl (pH
7.5), 1 % Tergitol, 0.1 % SDS, 1 % sodium deoxycholate,
150 mM NaCl, and proteolytic enzyme inhibitors (Protease
Inhibitor Cocktail, Sigma, St Louis, MO). After debris separa-
tion by centrifugation for 45min at 14,000×g, the supernatants
were collected and the protein concentration was determined
using a BCA Protein Assay kit (Pierce, Rockford, IL). All
samples were stored at −80 °C until analysis.
Injured muscle area
Serial muscle cross-sections for histology were obtained
(one section of 10 μm in each 100 μm of tissue) using a
cryostat microtome (Microm HE 505, Jena, Germany),
across the middle of the TA muscle.
Formorphometric evaluationby lightmicroscopy (Axiolab,
Carl Zeiss, Jena, Germany) tissue sections were stained using
toluidine blue. One histological cross-section of each TAmus-
cle located in the central region of muscle injury was chosen to
measure the cross-sectional area of both injured and uninjured
muscle, using software for morphometry (Axiovision 3.0.6
SP4, Carl Zeiss). Images were used to reconstruct the total
muscle cross-section area, allowing the identification andmea-
surement of both injured and uninjured areas. A double-blind
procedure was used for bothmuscle cross-section image selec-
tion and injured and uninjured muscle area measurements.
Total RNA isolation and real-time polymerase chain reaction
Tissue fragments were homogenized in 1 mL TRIzol®
reagent according to the manufacturer’s instructions (Invi-
trogen Life Science, Carlsbad, CA). RNA integrity was
assessed by 260/268 nm ratio and by 1 % agarose gel
electrophoresis stained with ethidium bromide.
Two nanograms of mRNAwas used to carry out real-time
PCR. The amplification was performed in a thermal cycler
(Applied Biosystems StepOneTM, Foster City, CA) at 50 °C
for 10 min, 95 °C for 5 min and then 95 °C for 15 s followed
by 60 °C for 30 s and 72 °C for 30 s for 40 cycles. Real-time
PCR was performed in a 15 μl reaction mixture containing
7.5 μl 2× SYBR Green Reaction Mix (Invitrogen), 0.3 μl
each primer, 0.3 μl Super Script III RT/Platinum Taq Mix
(10 pmol/μl), 0.15 μl ROX Reference Dye and 5 μl sample
in water. Quantification was performed by 2−ΔΔCT method,
using glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as housekeeping gene. This gene was chosen
after genome analysis (http://medgen.ugent.be/~jvdesomp/
genorm/) of five housekeeping genes. The following pri-
mers were used: MyoD forward: TAC GAC GCC GCC
TAC TAC AGT G; reverse: GCA TCG CTT GAG GAT
GTC TCC; Myogenin forward: AGG AAG TC TGT
GTC TGT GGA CC; reverse: TGT ACT GGA TGG
CAC TGC G; VEGF forward: TGA GAC CCT GGT
GGA CAT CTT C; reverse: TCC TAT GTG CTG GCT
TTG GTG; TGF-β1 forward: CCT ACA TTT GGA
GCC TGG ACA C; reverse: CAC GAT CAT GTT
GGA CAA CTG C; GAPDH forward: ATG ATT CTA
CCC ACG GCA AG; reverse: CTG GAA GATGGT
GAT GGG TT.
Immunoblotting
Protein expression was performed using SDS-polyacrylamide
gel electrophoresis under reducing conditions. Tissue extracts
(50 μg) were boiled in equal volumes of loading buffer
(150 mM Tris–HCl—pH6.8, 4 % SDS, 20 % glycerol, 15 %
β-mercaptoethanol and 0.01 % bromophenol blue) and were
subjected to electrophoresis in 9 % non-denaturing polyacryl-
amide gel. Following electrophoretic separation, proteins
were transferred to Hybond-P membranes (Amersham Phar-
macia Biotech, Buckinghamshire, UK). Membrane was
blocked with 5 % non-fat dry milk in Tris-buffered saline
and 0.5 % Tween 20 (TBST) for 1 h. Primary antibody (Ab)
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against the following was employed: Collagen I (goat poly-
clonal, 1:1000, Santa Cruz). Ab was diluted in TBST with
0.5 % bovine serum albumin and incubated in 4 °C overnight.
After washing twice with TBST, secondary Ab horseradish
peroxidase conjugate (Sigma Aldrich, St. Louis, MO) was
applied at dilution 1:1,000 for 1 h. Blot was washed in TBST
for 30min, incubated in enhanced chemiluminesence reagents
(Super signal detection kit, Pierce) and exposed and photo-
graphed using GBox Gel Document System (Syngene, Fred-
erick, MD). The band intensity was quantified using Gene
Tools software (Syngene).
Statistical analysis
Data are expressed as the mean ± standard error of the
mean. Shapiro–Wilk’s and Levene’s test were applied to
evaluate the normality and homogeneity of the results,
respectively. Comparisons between experimental groups
were performed by analysis of variance (one-way
ANOVA), and the Tukey post-test used to compare
individual groups. A P value <0.05 was considered
significant. All analyses were performed using Sigma
Stat Statistical Software (v.3.1).
Results
Tibialis anterior muscle weight and muscle injury area
There was no significant difference in the weight of the
tibialis anterior muscle among the groups (p>0.05; Table 1).
The total and percentual injured area in the LLLT-treated
group were statistically lower than in the comparable areas
in the non-treated injured muscles (IRI; p<0.05 vs IC).
Representative images of the TA muscle sections are
shown in Fig. 2. Injured groups show a homogeneous and
well-defined lesion area, with fascicular disorganization,
edema, tissue necrosis, and abundant extracellular matrix
deposition (arrowheads). IRI group showed a repaired area
(asterisk) on the surface of the tissue. The intact area was
indicated by arrows.
Transcripts of the regeneration markers: MyoD, myogenin,
and VEGF
After production of the muscle lesion, the MyoD gene
expression level was increased 13-fold and the myoge-
nin gene expression level was increased 90-fold com-
pared to uninjured controls (IC and IRI; p<0.01 vs BC;
Fig. 3 A and B). MyoD mRNA was further increased
more than twice by LLLT (IRI, 37.22±0.32 vs IC,
12.04±0.03) and myogenin mRNA also showed a small
but significant increase compared to muscle lesion alone
(IC, 92.74±0.2) after LLLT (IRI, 103.10±0.2). Both
increases after LLLT were significantly higher than the
non-LLLT group (IRI, p<0.01 vs IC).
VEGF gene expression levels showed the same pat-
tern observed in the myoD and myogenin mRNA quan-
tification. VEGF levels were two times higher in injured
muscle groups (IC, 2.08±0.1 and IRI, 2.38±0.2) com-
pared to control group (BC, p<0.01; Fig. 4). LLLT
further increased the expression of VEGF mRNA by a
small but significant extent compared to non-LLLT
group (IRI, p<0.05 vs IC).
Fig. 1 Freezing right tibialis
anterior muscle injury
(cryoinjury) model. a Dissec-
tion and muscle exposition; b
and c cryolesion procedure; d
suture after surgical procedure
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Expression of scar markers: TGF-β and type I collagen
The cryolesion increased TGF-β gene transcription in the
muscle homogenate 60-fold (IC, 60.39±0.15 and IRI, 42.92
±0.12; p<0.01 vs BC; Fig. 5A). LLLT significantly reduced
TGF-β gene expression by 25 % in injured muscle (IRI, p<
0.01 vs IC).
Collagen type I production in the muscle tissue was
fivefold-elevated after cryolesion (IC, 5080.2±339.0) when
compared with non-injured group (p<0.01; Fig. 5B). LLLT
reduced collagen I expression again by about 25 % in IRI
group (3681.3±263.23; p<0.01 vs IC). There was a there-
fore a good correlation between reduced collagen produc-
tion and reduced TGF-β expression.
Discussion
In spite of the fact that many studies of LLLT on muscle
injury have demonstrated its beneficial effects [19–22, 30],
little is known about how exactly LLLT is able to affect
cellular systems involved in muscle repair and what are the
molecular mechanisms involved in these processes. Herein,
we have shown that LLLT improved skeletal muscle regen-
eration by reducing the injured area, increasing myoD,
myogenin, and VEGF gene expression and, simultaneously,
reducing TGF-β mRNA and type I collagen deposition in
the injured tissue. Therefore, LLLT can increase muscle
regeneration markers and reduce scar tissue formation
which should favor tissue repair in muscle injuries.
The regeneration of skeletal muscle process is initiated
by mechanical or chemical stimuli that lead to activation of
quiescent satellite cells [31]. Even though the precise cause
of the transition from the quiescent state to the activated
state in satellite cells is unknown, some studies have pro-
posed that disrupting the integrity of the sarcolemma and
basal lamina causes mechanical stress that can induce satel-
lite cell activation [32]. Many authors have proposed that
the injury-stimulated release of substances such as cyto-
kines, prostaglandins, nitric oxide could stimulate satellite
cell activation [3, 5]. It is likely that there is a complex
combination of these and other cellular events in which the
use of LLLT might have an additional stimulating role [33,
34] on expression of transcription factors in the MRFs, such
Table 1 Muscle weight, injury and uninjured cross-section area of TA muscle middle belly
Groups Muscle weight (g) Total area mm2 Injured area mm2 Injured area (% total area)
BC 0.46±0.05 50.04±4.7 – –
IC 0.44±0.06 53.89±5.3 20.99±23 38.94
IRI 0.45±0.04 53.39±1.4 15.98±14* 29.93*
Data are means (±SD). Normal TA muscle (BC); TA muscle injured (IC); TA muscle injured submitted to infrared laser irradiation (IRI)
*p<0.05: compared to injured area of IC group
Fig. 2 Morphometric analysis of middle TA muscle cross-sections.
Micrography of typical toluidine blue-stained muscle sections. Injured
area (arrowhead), intact area (arrows) and reparative area (asterisk).
Normal TA muscle—control (BC); injured TA muscle without LLLT
(IC); injured TA muscle with LLLT (IRI)
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as myoD and myogenin. Some studies have shown that
myoD and myogenin are traditionally considered markers
of muscle growth and hypertrophy, as they can regulate the
division of satellite cells and lead to incorporation of new
myonuclei into mature muscle fibers. These transcription
factors are expressed in the adult skeletal muscle in response
to several stimuli, such as overcharge, denervation, and
stretch, suggesting that myoD and myogenin have an im-
portant role in skeletal muscle regeneration [35]. In the
present study, we observed that induction of cryolesion in
the tibialis anterior muscle generated an increase in the
transcription of myogenic factors, myoD and myogenin.
However, there was an additional significant effect of LLLT
in further increasing these markers.
LLLT has been reported to activate quiescent satellite
cells and cause them to enter cell cycle and initiate
proliferation [19, 34, 36]. Shefer et al. demonstrated
that LLLT regulated proteins essential for the initial
phase of protein synthesis in myoblasts (through
MAPK/ERK) [34]. The same authors observed that the
mean number of cells per fiber was tripled in the LLLT-
irradiated group compared to control group [20]. Treat-
ment with a GaAlAs laser (830 nm) was able to enlarge
the muscle fiber diameter that had undergone atrophy
[27]. Although there are still many questions to be
clarified about the molecular mechanisms by which
LLLT causes these effects, we suggest that in this mod-
el, the increase in myogenic factors favored satellite cell
activation and muscle repair.
The increase in myoD and myogenin expression corre-
lated with the results obtained in the morphometric analysis,
where a reduction in the injured muscle area in the LLLT
group was seen. This led us to infer that the regulation of
transcription factors responsible for activation of satellite
cells by LLLT contributed to new muscle fiber formation
and to the reduction of the injured area.
Angiogenesis, stimulated by VEGF among other factors,
is also essential for the formation of new muscle fibers after
muscle damage. Angiogenesis is an important requirement
for functional and morphological recovery of the injured
muscle [11], as it restores injured blood vessels, promotes
local blood flow, and restores a supply of oxygen and
nutrients to the injured tissue.
Fig. 3 Effect of LLLT on
MyoD and myogenin gene
expression. a MyoD mRNA
and b myogenin mRNA
Fig. 4 Effect of LLLT on VEGF gene expression
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Wagatsuma et al. showed that VEGF mRNA levels in-
creased on the third day after cryolesion in murine gastroc-
nemius muscle [14]. Similarly in the present study, LLLT
increased levels of this growth factor. In vivo studies in
different regeneration models have highlighted the effect
of LLLT in angiogenesis induction [37, 38]. It has been
proposed that LLLT is able to increase the formation of
new capillary vessels through the increased release of
growth factors, such as VEGF [24, 38]. Our laboratory
was able to confirm that LLLT induces angiogenesis
through upregulating hypoxia-inducible factor (HIF-1α),
increasing VEGF mRNA levels and increased formation of
new blood vessels in rat skin (Cury et al., unpublished data).
Increased expression of VEGF in this model could be con-
sidered an important contributor to muscle regeneration.
It is likely that recovery of the injured muscle function is
dependent on an equilibrium between regeneration and fi-
brosis. This equilibrium is affected by the intensity of the
acute inflammatory response, by satellite cells activation,
and by expression of several growth factors and cytokines,
especially TGF-β, present in the site of lesion [3]. There-
fore, we decided to evaluate the possible effect of LLLT on
TGF-β and collagen deposition in the site of lesion.
We found LLLT reduced TGF-β gene expression,
lowered type I collagen deposition and could reduce
fibrous tissue formation in rat skeletal muscle. TGF-β
expression has a key role in the scar tissue formation
during muscle repair. It regulates extracellular matrix
component production and simultaneously blocks its
degradation. It is also known that an increase in TGF-
β production inhibits myoD expression and induces
myogenic cells to differentiate instead to myofibroblasts
able to produce type I collagen, thereby impairing mus-
cle regeneration [15]. Li et al. observed that TGF-β
stimulated C2C12 myoblasts to produce more TGF-β
in an autocrine mode, suppressing muscle protein ex-
pression and enhancing fibrosis-related proteins [16].
Fibrous tissue formation in the skeletal muscle impairs
regular muscle contraction, prompting pathological contrac-
tures and causing chronic muscle pain. In this scenario, there
can be an intense deposition of collagen between the capil-
lary vessels and the membrane of myofibrils that reduces
nutrient support. TGF-β inactivation reduces fibrous tissue
formation and improves the contractile properties of the
repairing muscle [39]. Based on this information, our results
suggest that LLLT had a positive effect, reducing TGF-β
expression and, as a consequence, decreasing local collagen
accumulation, preventing fibrous tissue formation and
prompting skeletal muscle recovery.
Filliping et al. reported that an infrared laser (904 nm)
reduced collagen deposition in rat tendons [40]. Rizzi et al.
also detected reduced collagen expression after 904-nm
laser treatment and suggested that NF-κB inactivation by
LLLT could be the mechanism that regulated collagen pro-
duction [41]. Mesquita-Ferrari et al. treated rat muscle with
LLLT (660 nm) and found lower expression levels of TGF-
β and TNF-α in the muscle fiber when the treatment ended,
which supported fibrosis prevention and muscle contractil-
ity improvement [22]. Since TGF-β1 directly regulates col-
lagen deposition, this growth factor is associated with
Fig. 5 Effect of LLLT on TGF-
β gene expression and Type I
collagen protein expression. a
TGF-β mRNA and b Type I
collagen I protein expression
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complications arising in the muscle repair process, and
therefore LLLT could be a good therapeutic approach for
muscle repair.
In summary, our results indicate that near-infrared laser
(808 nm) at the dose selected was able to improve skeletal
muscle regeneration, increase myogenic regulatory factors
(myoD and myogenin) and stimulate VEGF expression in
an experimental animal model. Additionally, TGF-β1 and
type I collagen mRNA were reduced in the lesion area,
reducing skeletal muscle fibrosis. LLLT is inexpensive,
non-invasive, and without reported side effects, and could
therefore become a treatment of choice in patients with
muscle injury. Nevertheless, more thorough investigations
of the molecular mechanisms are needed to clarify how
LLLT functions in muscle regeneration and fibrotic disor-
ders in general.
Acknowledgments We acknowledge CAPES, CNPQ and FAPESP
for financial support. MR Hamblin was supported by NIH (grant
R01AI050875). Emergency Medicine Division (LIM 51), Faculdade
de Medicina da Universidade de São Paulo to provide technical sup-
port in biochemical and molecular biology analyses and NUPEN
(Núcleo de Pesquisa e Ensino em Fototerapia nas Ciências da Saúde)
for supporting and calibrating the laser equipment.
Disclosure of interests The authors indicate no potential conflict of
interests.
References
1. Huard J, Li Y, Fu FH (2002) Muscle injuries and repair: current
trends in research. J Bone Joint Surg Am 84-A(5):822–832
2. Jarvinen TA, Jarvinen TL, Kaariainen M, Kalimo H, Jarvinen M
(2005) Muscle injuries: biology and treatment. Am J Sports Med
33(5):745–764. doi:10.1177/0363546505274714
3. Filippin LI, Cuevas MJ, Lima E, Marroni NP, Gonzalez-Gallego J,
Xavier RM (2011) Nitric oxide regulates the repair of injured
skeletal muscle. Nitric Oxide 24(1):43–49. doi:10.1016/
j.niox.2010.11.003
4. Charge SB, Rudnicki MA (2004) Cellular and molecular regula-
tion of muscle regeneration. Physiol Rev 84(1):209–238.
doi:10.1152/physrev.00019.2003
5. Ehrhardt J, Morgan J (2005) Regenerative capacity of skeletal
muscle. Curr Opin Neurol 18(5):548–553
6. Le Grand F, Rudnicki MA (2007) Skeletal muscle satellite cells
and adult myogenesis. Curr Opin Cell Biol 19(6):628–633.
doi:10.1016/j.ceb.2007.09.012
7. SakumaK,WatanabeK, SanoM, Uramoto I, SakamotoK, Totsuka T
(1999) The adaptive response of MyoD family proteins in over-
loaded, regenerating and denervated rat muscles. Biochim Biophys
Acta 1428(2–3):284–292
8. Shi X, Garry DJ (2006) Muscle stem cells in development, regen-
eration, and disease. Genes Dev 20(13):1692–1708. doi:10.1101/
gad.1419406
9. Rantanen J, Hurme T, Lukka R, Heino J, Kalimo H (1995) Satellite
cell proliferation and the expression of myogenin and desmin in
regenerating skeletal muscle: evidence for two different popula-
tions of satellite cells. Lab Invest 72(3):341–347
10. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M,
Luster MI, Simeonova PP (2002) Physiological role of tumor
necrosis factor alpha in traumatic muscle injury. FASEB J 16
(12):1630–1632. doi:10.1096/fj.02-0187fje
11. Deveci D, Marshall JM, Egginton S (2002) Chronic hypoxia
induces prolonged angiogenesis in skeletal muscles of rat. Exp
Physiol 87(3):287–291
12. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006)
VEGF receptor signalling—in control of vascular function. Nat
Rev Mol Cell Biol 7(5):359–371. doi:10.1038/nrm1911
13. Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg
S, Pereira T, Yla-Herttuala S, Poellinger L, Brismar K, Catrina SB
(2008) Stabilization of HIF-1alpha is critical to improve wound
healing in diabetic mice. Proc Natl Acad Sci USA 105(49):19426–
19431. doi:10.1073/pnas.0805230105
14. Wagatsuma A (2007) Endogenous expression of angiogenesis-
related factors in response to muscle injury. Mol Cell Biochem
298(1–2):151–159. doi:10.1007/s11010-006-9361-x
15. Kollias HD, McDermott JC (2008) Transforming growth factor-
beta and myostatin signaling in skeletal muscle. J Appl Physiol
104(3):579–587. doi:10.1152/japplphysiol.01091.2007
16. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J,
Huard J (2004) Transforming growth factor-beta1 induces the
differentiation of myogenic cells into fibrotic cells in injured
skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol
164(3):1007–1019
17. Hamblin MR (2010) Introduction to experimental and clinical
studies using low-level laser (light) therapy (LLLT). Lasers Surg
Med 42(6):447–449. doi:10.1002/lsm.20959
18. Demidova-Rice TN, Salomatina EV, Yaroslavsky AN, Herman
IM, Hamblin MR (2007) Low-level light stimulates excisional
wound healing in mice. Lasers Surg Med 39(9):706–715.
doi:10.1002/lsm.20549
19. Ben-Dov N, Shefer G, Irintchev A, Wernig A, Oron U, Halevy O
(1999) Low-energy laser irradiation affects satellite cell prolifera-
tion and differentiation in vitro. Biochim Biophys Acta 1448
(3):372–380
20. Shefer G, Barash I, Oron U, Halevy O (2003) Low-energy laser
irradiation enhances de novo protein synthesis via its effects on
translation-regulatory proteins in skeletal muscle myoblasts. Bio-
chim Biophys Acta 1593(2–3):131–139
21. Renno AC, Toma RL, Feitosa SM, Fernandes K, Bossini PS, de
Oliveira P, Parizotto N, Ribeiro DA (2011) Comparative effects of
low-intensity pulsed ultrasound and low-level laser therapy on
injured skeletal muscle. Photomed Laser Surg 29(1):5–10.
doi:10.1089/pho.2009.2715
22. Mesquita-Ferrari RA, Martins MD, Silva JA Jr, da Silva TD,
Piovesan RF, Pavesi VC, Bussadori SK, Fernandes KP (2011)
Effects of low-level laser therapy on expression of TNF-alpha
and TGF-beta in skeletal muscle during the repair process. Lasers
Med Sci 26(3):335–340. doi:10.1007/s10103-010-0850-5
23. Iyomasa DM, Garavelo I, Iyomasa MM, Watanabe IS, Issa JP
(2009) Ultrastructural analysis of the low level laser therapy effects
on the lesioned anterior tibial muscle in the gerbil. Micron 40
(4):413–418. doi:10.1016/j.micron.2009.02.002
24. Tuby H, Maltz L, Oron U (2006) Modulations of VEGF and iNOS
in the rat heart by low level laser therapy are associated with
cardioprotection and enhanced angiogenesis. Lasers Surg Med 38
(7):682–688. doi:10.1002/lsm.20377
25. Amaral AC, Parizotto NA, Salvini TF (2001) Dose-dependency of
low-energy HeNe laser effect in regeneration of skeletal muscle in
mice. Lasers Med Sci 16(1):44–51
26. Silveira PC, Silva LA, Fraga DB, Freitas TP, Streck EL, Pinho R
(2009) Evaluation of mitochondrial respiratory chain activity in
muscle healing by low-level laser therapy. J Photochem Photobiol
B 95(2):89–92. doi:10.1016/j.jphotobiol.2009.01.004
954 Lasers Med Sci (2013) 28:947–955
27. Nakano J, Kataoka H, Sakamoto J, Origuchi T, Okita M, Yoshimura
T (2009) Low-level laser irradiation promotes the recovery of atro-
phied gastrocnemius skeletal muscle in rats. Exp Physiol 94
(9):1005–1015. doi:10.1113/expphysiol.2009.047738
28. Cressoni MD, Dib Giusti HH, Casarotto RA, Anaruma CA (2008)
The effects of a 785-nm AlGaInP laser on the regeneration of rat
anterior tibialis muscle after surgically-induced injury. Photomed
Laser Surg. doi:10.1089/pho.2007.2150
29. Miyabara EH, Martin JL, Griffin TM, Moriscot AS, Mestril R
(2006) Overexpression of inducible 70-kDa heat shock protein in
mouse attenuates skeletal muscle damage induced by cryolesion-
ing. Am J Physiol Cell Physiol 290(4):C1128–C1138.
doi:10.1152/ajpcell.00399.2005
30. Servetto N, Cremonezzi D, Simes JC, Moya M, Soriano F, Palma
JA, Campana VR (2010) Evaluation of inflammatory biomarkers
associated with oxidative stress and histological assessment of
low-level laser therapy in experimental myopathy. Lasers Surg
Med 42(6):577–583. doi:10.1002/lsm.20910
31. Holterman CE, Rudnicki MA (2005) Molecular regulation of
satellite cell function. Semin Cell Dev Biol 16(4–5):575–584.
doi:10.1016/j.semcdb.2005.07.004
32. Hurme T, Kalimo H (1992) Activation of myogenic precursor cells
after muscle injury. Med Sci Sports Exerc 24(2):197–205
33. Shefer G, Oron U, Irintchev A, Wernig A, Halevy O (2001) Skeletal
muscle cell activation by low-energy laser irradiation: a role for the
MAPK/ERK pathway. J Cell Physiol 187(1):73–80. doi:10.1002/
1097-4652(2001)9999:9999<::AID-JCP1053>3.0.CO;2-9
34. Shefer G, Partridge TA, Heslop L, Gross JG, Oron U, Halevy O
(2002) Low-energy laser irradiation promotes the survival and cell
cycle entry of skeletal muscle satellite cells. J Cell Sci 115(Pt
7):1461–1469
35. Gomes AR, Soares AG, Peviani S, Nascimento RB, Moriscot AS,
Salvini TF (2006) The effect of 30 min of passive stretch of the rat
soleus muscle on the myogenic differentiation, myostatin, and
atrogin-1 gene expressions. Arch Phys Med Rehabil 87(2):241–
246. doi:10.1016/j.apmr.2005.08.126
36. Oron U (2006) Photoengineering of tissue repair in skeletal and
cardiac muscles. Photomed Laser Surg 24(2):111–120.
doi:10.1089/pho.2006.24.111
37. Bibikova A, Belkin V, Oron U (1994) Enhancement of angiogen-
esis in regenerating gastrocnemius muscle of the toad (Bufo vir-
idis) by low-energy laser irradiation. Anat Embryol (Berl) 190
(6):597–602
38. Kipshidze N, Nikolaychik V, Keelan MH, Shankar LR,
Khanna A, Kornowski R, Leon M, Moses J (2001) Low-
power helium: neon laser irradiation enhances production of
vascular endothelial growth factor and promotes growth of
endothelial cells in vitro. Lasers Surg Med 28(4):355–364.
doi:10.1002/lsm.1062
39. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J (2001)
The use of an antifibrosis agent to improve muscle recovery after
laceration. Am J Sports Med 29(4):394–402
40. Fillipin LI, Mauriz JL, Vedovelli K, Moreira AJ, Zettler CG, Lech
O, Marroni NP, Gonzalez-Gallego J (2005) Low-level laser thera-
py (LLLT) prevents oxidative stress and reduces fibrosis in rat
traumatized Achilles tendon. Lasers Surg Med 37(4):293–300.
doi:10.1002/lsm.20225
41. Rizzi CF, Mauriz JL, Freitas Correa DS, Moreira AJ, Zettler CG,
Filippin LI, Marroni NP, Gonzalez-Gallego J (2006) Effects of
low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB
signaling pathway in traumatized muscle. Lasers Surg Med 38
(7):704–713. doi:10.1002/lsm.20371
Lasers Med Sci (2013) 28:947–955 955
